跳至主要内容
临床试验/JPRN-UMIN000003797
JPRN-UMIN000003797已完成未知

Carbon ion radiotherapy for stage I non-small cell lung cancer - Carbon ion radiotherapy for stage I non-small cell lung cancer

Gunma University Heavy Ion Medical Center0 个研究点目标入组 37 人开始时间: 2010年6月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
37

研究概览

简要总结

The median follow-up period was 56.3 months for all patients and 62.2 months for living patients. The actuarial 2-year, 3-year, and 5-year local control rates were 91.2%, 88.1%, and 88.1%, respectively. The actuarial 2-year, 3-year, and 5-year overall survival rates were 91.9%, 80.0%, and 74.9%, respectively. No patients with T1 disease experienced toxicities in grade 2 or worse severity.

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. past history of irradiation to the target 2. past history of chemotherapy within 4 weeks before treatment 3. life expectancy less than 6 months 4. Uncontrolled infection of lung 5. Active interstitial lung disease 6. Active double cancers 7. Other medical or psychological unsuitable reasons

研究者

发起方
Gunma University Heavy Ion Medical Center

相似试验